The Inside Story: How New York Nephrologists, National Suppliers Made Creative Adaptations to Cope with COVID-19 Surge

Restricted access

As COVID-19 patients began to flood New York City area hospitals in February, they developed acute kidney injury (AKI) at rates much higher than anyone expected from a respiratory virus. By mid-April, the need for renal replacement therapy in these patients was pushing the system to the breaking point, as healthcare providers and manufacturers scrambled to find equipment and supplies.

Hospitals used creative means to cope—including contacting the top decision-makers at the largest companies directly to plead for help and finding ways to treat more patients with a limited number of machines.

Because COVID-19 is categorized as a respiratory infection,